Disclosures for "Management of Post-infectious Central Nervous System (CNS) Vasculitis in a Patient with Cryptococcus Meningitis and Recurrent Ventriculomegaly on Long-term Antifungal Therapy"
-
Dr. Sblendorio has nothing to disclose.
-
Dr. Seachrist has or had stock in Medtronic.Dr. Seachrist has or had stock in Pfizer. The institution of Dr. Seachrist has received research support from Bristol Myers Squibb. Dr. Seachrist has a non-compensated relationship as a Topic Group, QOD Committee, and Wellness Program Committee with American Academy of Neurology that is relevant to AAN interests or activities.
-
Dr. Hyde has nothing to disclose.
-
Dr. Sultan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion.